- Home
- LESL vs IKT Comparison
LESL vs IKT Comparison
Compare LESL & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LESL
- IKT
- Stock Information
- Founded
- LESL 1963
- IKT 2008
- Country
- LESL United States
- IKT United States
- Employees
- LESL N/A
- IKT N/A
- Industry
- LESL Diversified Commercial Services
- IKT Biotechnology: Pharmaceutical Preparations
- Sector
- LESL Miscellaneous
- IKT Health Care
- Exchange
- LESL Nasdaq
- IKT Nasdaq
- Market Cap
- LESL 116.5M
- IKT 139.0M
- IPO Year
- LESL 2020
- IKT 2020
- Fundamental
- Price
- LESL $0.76
- IKT $2.01
- Analyst Decision
- LESL Hold
- IKT Buy
- Analyst Count
- LESL 11
- IKT 2
- Target Price
- LESL $2.32
- IKT $8.00
- AVG Volume (30 Days)
- LESL 2.5M
- IKT 123.6K
- Earning Date
- LESL 05-08-2025
- IKT 05-14-2025
- Dividend Yield
- LESL N/A
- IKT N/A
- EPS Growth
- LESL N/A
- IKT N/A
- EPS
- LESL N/A
- IKT N/A
- Revenue
- LESL $1,319,859,000.00
- IKT N/A
- Revenue This Year
- LESL $1.87
- IKT N/A
- Revenue Next Year
- LESL $2.73
- IKT N/A
- P/E Ratio
- LESL N/A
- IKT N/A
- Revenue Growth
- LESL N/A
- IKT N/A
- 52 Week Low
- LESL $0.51
- IKT $1.12
- 52 Week High
- LESL $6.01
- IKT $4.20
- Technical
- Relative Strength Index (RSI)
- LESL 47.97
- IKT 49.69
- Support Level
- LESL $0.76
- IKT $1.70
- Resistance Level
- LESL $0.90
- IKT $2.12
- Average True Range (ATR)
- LESL 0.07
- IKT 0.19
- MACD
- LESL -0.01
- IKT 0.01
- Stochastic Oscillator
- LESL 10.74
- IKT 54.39
About LESL Leslie's Inc.
Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products across chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company offers its products and services for Residential Pool, Residential Spa, Professional Pool, and Commercial Pool consumers. Geographically, it operates only in the United States.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.